In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 24th, 2010 | 43 | No |
Popular Name: Bromocriptine Bromocriptine
Find On: PubMed — Wikipedia — Google
CAS Numbers: 22260-51-1 , 25614-03-3
(+)-Bromocriptine methanesulfonate
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione
(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman methanesulfonate
.alpha.-Ergocryptine, 2-bromo-, methanesulfonate
2-Bromine-alpha-ergocryptine methanesulfonate
2-Bromo-.alpha.-ergocryptine monomethanesulfonate
2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3',6',18-trione
2-Bromo-12'-hydroxy-5'alpha-isobutyl-2'-isopropylergotaman-3',6',18-trione monomethanesulphonate
2-Bromo-alpha-ergocryptine mesylate
2-Bromo-alpha-ergocryptine methanesulfonate
2-Bromo-alpha-ergokryptine-mesilate
2-Bromo-alpha-ergokryptine-mesilate [German]
2-Bromoergocryptine Methanesulfonate
2-Bromoergocryptine monomethanesulfonate (salt)
22260-51-1; Bromocriptine mesilate (JP16); Bromocriptine mesylate (USP); D00780; Parlodel (TN)
22260-51-1; Bromocryptine mesylate; Prestwick_771
25614-03-3; Bromocriptine (USAN/INN); D03165
25614-03-3; Bromocriptine; C06856
alpha-Ergocryptine, 2-bromo-, methanesulfonate
Bromocriptine Methanesulfonate
Bromocryptine methanesulfonate
CB 154 methanesulfonate (salt)
Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'alpha)-
Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-,(5'-alpha)-
Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(2-methylpropyl)-
USAN); Bromocriptine Mesilate (JAN)
USAN); Bromocriptine Mesilate (JAN); Bromocriptine Mesylate (FDA
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.60 | 7.13 | -16.86 | 3 | 10 | 0 | 118 | 654.606 | 5 | ↓ |
Hi High (pH 8-9.5) | 3.60 | 7.64 | -47.34 | 2 | 10 | -1 | 121 | 653.598 | 5 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 8.58e-02 g/l | DrugBank-approved |
Patent Database Links | EP1099438; EP1136071; EP1148054; EP1254661; EP1256343; EP1568770; EP1576985; EP1661571; EP1666040; EP1776955; EP1815854; EP1870096; EP1952813; EP1987815; US2002128247; US2002147336; US2003026850; US2004077694; US2004077716; US2004087659; US2004110951; US2 | ChEBI |
UniProt Database Links | PRLHR_HUMAN | ChEBI |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
5HT1A-1-E | Serotonin 1a (5-HT1a) Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 24 | 0.25 | Binding ≤ 10μM |
5HT6R-2-E | Serotonin 6 (5-HT6) Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 50 | 0.24 | Binding ≤ 10μM |
ADA1A-1-E | Alpha-1a Adrenergic Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 514 | 0.20 | Binding ≤ 10μM |
ADA2A-1-E | Alpha-2a Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 514 | 0.20 | Binding ≤ 10μM |
ADA2B-1-E | Alpha-2b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 514 | 0.20 | Binding ≤ 10μM |
ADA2C-1-E | Alpha-2c Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 514 | 0.20 | Binding ≤ 10μM |
DRD1-1-E | Dopamine D1 Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 28 | 0.25 | Binding ≤ 10μM |
DRD3-1-E | Dopamine D3 Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 87 | 0.23 | Binding ≤ 10μM |
DRD4-1-E | Dopamine D4 Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 28 | 0.25 | Binding ≤ 10μM |
DRD5-1-E | Dopamine D5 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 28 | 0.25 | Binding ≤ 10μM |
CP3A4-2-E | Cytochrome P450 3A4 (cluster #2 Of 4), Eukaryotic | Eukaryotes | 2999 | 0.18 | ADME/T ≤ 10μM |
DRD2-4-E | Dopamine D2 Receptor (cluster #4 Of 24), Eukaryotic | Eukaryotes | 8 | 0.26 | Binding ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 1585 | 0.19 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ADA1A_BOVIN | P18130 | Alpha-1a Adrenergic Receptor, Bovin | 514 | 0.20 | Binding ≤ 1μM |
ADA2A_BOVIN | Q28838 | Alpha-2a Adrenergic Receptor, Bovin | 514 | 0.20 | Binding ≤ 1μM |
ADA2A_RAT | P22909 | Alpha-2a Adrenergic Receptor, Rat | 514 | 0.20 | Binding ≤ 1μM |
ADA2B_RAT | P19328 | Alpha-2b Adrenergic Receptor, Rat | 514 | 0.20 | Binding ≤ 1μM |
ADA2C_RAT | P22086 | Alpha-2c Adrenergic Receptor, Rat | 514 | 0.20 | Binding ≤ 1μM |
DRD1_RAT | P18901 | Dopamine D1 Receptor, Rat | 27.9 | 0.25 | Binding ≤ 1μM |
DRD2_RAT | P61169 | Dopamine D2 Receptor, Rat | 17 | 0.25 | Binding ≤ 1μM |
DRD2_HUMAN | P14416 | Dopamine D2 Receptor, Human | 10 | 0.26 | Binding ≤ 1μM |
DRD3_RAT | P19020 | Dopamine D3 Receptor, Rat | 27.9 | 0.25 | Binding ≤ 1μM |
DRD3_HUMAN | P35462 | Dopamine D3 Receptor, Human | 87 | 0.23 | Binding ≤ 1μM |
DRD4_RAT | P30729 | Dopamine D4 Receptor, Rat | 27.9 | 0.25 | Binding ≤ 1μM |
DRD5_RAT | P25115 | Dopamine D5 Receptor, Rat | 27.9 | 0.25 | Binding ≤ 1μM |
5HT1A_HUMAN | P08908 | Serotonin 1a (5-HT1a) Receptor, Human | 24 | 0.25 | Binding ≤ 1μM |
5HT6R_HUMAN | P50406 | Serotonin 6 (5-HT6) Receptor, Human | 50 | 0.24 | Binding ≤ 1μM |
ADA1A_BOVIN | P18130 | Alpha-1a Adrenergic Receptor, Bovin | 514 | 0.20 | Binding ≤ 10μM |
ADA2A_RAT | P22909 | Alpha-2a Adrenergic Receptor, Rat | 514 | 0.20 | Binding ≤ 10μM |
ADA2A_BOVIN | Q28838 | Alpha-2a Adrenergic Receptor, Bovin | 514 | 0.20 | Binding ≤ 10μM |
ADA2B_RAT | P19328 | Alpha-2b Adrenergic Receptor, Rat | 514 | 0.20 | Binding ≤ 10μM |
ADA2C_RAT | P22086 | Alpha-2c Adrenergic Receptor, Rat | 514 | 0.20 | Binding ≤ 10μM |
DRD1_RAT | P18901 | Dopamine D1 Receptor, Rat | 27.9 | 0.25 | Binding ≤ 10μM |
DRD2_RAT | P61169 | Dopamine D2 Receptor, Rat | 17 | 0.25 | Binding ≤ 10μM |
DRD2_HUMAN | P14416 | Dopamine D2 Receptor, Human | 10 | 0.26 | Binding ≤ 10μM |
DRD3_RAT | P19020 | Dopamine D3 Receptor, Rat | 27.9 | 0.25 | Binding ≤ 10μM |
DRD3_HUMAN | P35462 | Dopamine D3 Receptor, Human | 87 | 0.23 | Binding ≤ 10μM |
DRD4_RAT | P30729 | Dopamine D4 Receptor, Rat | 27.9 | 0.25 | Binding ≤ 10μM |
DRD5_RAT | P25115 | Dopamine D5 Receptor, Rat | 27.9 | 0.25 | Binding ≤ 10μM |
5HT1A_HUMAN | P08908 | Serotonin 1a (5-HT1a) Receptor, Human | 24 | 0.25 | Binding ≤ 10μM |
5HT6R_HUMAN | P50406 | Serotonin 6 (5-HT6) Receptor, Human | 50 | 0.24 | Binding ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 1258.92541 | 0.19 | Functional ≤ 10μM |
CP3A4_HUMAN | P08684 | Cytochrome P450 3A4, Human | 2999.16252 | 0.18 | ADME/T ≤ 10μM |
Description | Species |
---|---|
Adrenaline signalling through Alpha-2 adrenergic receptor | |
Adrenaline,noradrenaline inhibits insulin secretion | |
Adrenoceptors | |
Aflatoxin activation and detoxification | |
Dopamine receptors | |
G alpha (i) signalling events | |
G alpha (s) signalling events | |
G alpha (z) signalling events | |
Serotonin receptors | |
Xenobiotics |
No pre-computed analogs available. Try a structural similarity search.